Detalhe da pesquisa
1.
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Blood
; 141(6): 567-578, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399715
2.
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
; 137(6): 751-762, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929488
3.
Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia.
Am J Hematol
; 97(6): E191-E194, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35266185
4.
In the Era of BCR-ABL1 Inhibitors, Are We Closing the Survival Gap Between Allogeneic Hematopoietic Cell Transplantation and Chemotherapy for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in First Complete Remission?
Biol Blood Marrow Transplant
; 24(4): 637-638, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29474869
5.
Ph+ ALL in 2022: is there an optimal approach?
Hematology Am Soc Hematol Educ Program
; 2022(1): 206-212, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36485090
6.
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
J Clin Oncol
; 40(14): 1574-1582, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35157496
7.
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.
Blood Adv
; 6(1): 339-357, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547770
8.
Expression analysis of proline rich 15 (Prr15) in mouse and human gastrointestinal tumors.
Mol Carcinog
; 50(1): 8-15, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21061267
9.
Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: phase 3 post hoc analyses.
Blood Adv
; 5(6): 1719-1728, 2021 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724305
10.
Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial.
Clin Lymphoma Myeloma Leuk
; 21(3): 139-146, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33478921
11.
Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL.
Blood Adv
; 5(22): 4691-4700, 2021 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34492682
12.
CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial.
Lancet Haematol
; 8(7): e481-e491, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171279
13.
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR.
Leukemia
; 35(7): 2076-2085, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785862
14.
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
J Clin Oncol
; 39(29): 3261-3272, 2021 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34156898
15.
New approaches to the treatment of older adults with acute lymphoblastic leukemia.
Semin Hematol
; 57(3): 122-129, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256901
16.
CSF3R truncation mutations in a patient with B-cell acute lymphoblastic leukemia and a favorable response to chemotherapy plus dasatinib.
Leuk Res Rep
; 14: 100208, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577374
17.
Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia.
Blood Adv
; 4(3): 449-457, 2020 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32012214
18.
Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study.
Clin Cancer Res
; 26(5): 1000-1008, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31772119
19.
TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML.
Blood Adv
; 4(20): 5011-5024, 2020 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33057635
20.
Histone Deacetylase Inhibition with Panobinostat Combined with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: Phase I Study Results.
Clin Cancer Res
; 25(16): 4917-4923, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31152020